Literature DB >> 26231799

miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A.

Mingchen Shao1, Yiwei Geng1, Peng Lu2, Ying Xi1, Sidong Wei3, Liuxing Wang1, Qingxia Fan1, Wang Ma1.   

Abstract

MicroRNAs (miRNAs) play important roles in the pathogenesis of many types of cancers by negatively regulating gene expression at posttranscriptional level. However, the role of microRNAs in anaplastic thyroid carcinoma (ATC), has remained elusive. Here, we identified that miR-4295 promotes ATC cell proliferation by negatively regulates its target gene CDKN1A. In ATC cell lines, CCK-8 proliferation assay indicated that the cell proliferation was promoted by miR-4295, while miR-4295 inhibitor significantly inhibited the cell proliferation. Transwell assay showed that miR-4295 mimics significantly promoted the migration and invasion of ATC cells, whereas miR-4295 inhibitors significantly reduced cell migration and invasion. luciferase assays confirmed that miR-4295 directly bound to the 3'untranslated region of CDKN1A, and western blotting showed that miR-4295 suppressed the expression of CDKN1A at the protein levels. This study indicated that miR-4295 negatively regulates CDKN1A and promotes proliferation and invasion of ATC cell lines. Thus, miR-4295 may represent a potential therapeutic target for ATC intervention.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Anaplastic thyroid carcinoma; CDKN1A; miR-4295

Mesh:

Substances:

Year:  2015        PMID: 26231799     DOI: 10.1016/j.bbrc.2015.07.128

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Ginsenoside Rh2 inhibits prostate cancer cell growth through suppression of microRNA-4295 that activates CDKN1A.

Authors:  Qiruo Gao; Junhua Zheng
Journal:  Cell Prolif       Date:  2018-02-19       Impact factor: 6.831

2.  miR-544 inhibits the migration and invasion of anaplastic thyroid cancer by targeting Yin Yang-1.

Authors:  Feng Wang; Zhiqiang Li; Bo Sun
Journal:  Oncol Lett       Date:  2019-01-09       Impact factor: 2.967

3.  Treatment effect of CDKN1A on rheumatoid arthritis by mediating proliferation and invasion of fibroblast-like synoviocytes cells.

Authors:  X Gang; H Xu; L Si; X Zhu; T Yu; Z Jiang; Y Wang
Journal:  Clin Exp Immunol       Date:  2018-09-23       Impact factor: 4.330

4.  miR-130a Deregulates PTEN and Stimulates Tumor Growth.

Authors:  Huijun Wei; Ri Cui; Julian Bahr; Nicola Zanesi; Zhenghua Luo; Wei Meng; Guang Liang; Carlo M Croce
Journal:  Cancer Res       Date:  2017-09-21       Impact factor: 12.701

Review 5.  The role of microRNAs in different types of thyroid carcinoma: a comprehensive analysis to find new miRNA supplementary therapies.

Authors:  S Pishkari; M Paryan; M Hashemi; E Baldini; S Mohammadi-Yeganeh
Journal:  J Endocrinol Invest       Date:  2017-07-31       Impact factor: 4.256

6.  Unveiling massive numbers of cancer-related urinary-microRNA candidates via nanowires.

Authors:  Takao Yasui; Takeshi Yanagida; Satoru Ito; Yuki Konakade; Daiki Takeshita; Tsuyoshi Naganawa; Kazuki Nagashima; Taisuke Shimada; Noritada Kaji; Yuta Nakamura; Ivan Adiyasa Thiodorus; Yong He; Sakon Rahong; Masaki Kanai; Hiroshi Yukawa; Takahiro Ochiya; Tomoji Kawai; Yoshinobu Baba
Journal:  Sci Adv       Date:  2017-12-15       Impact factor: 14.136

Review 7.  miRNA dysregulation and the risk of metastasis and invasion in papillary thyroid cancer: a systematic review and meta-analysis.

Authors:  Tiantian Wang; Hao Xu; Ming Qi; Sheng Yan; Xingsong Tian
Journal:  Oncotarget       Date:  2017-03-29

8.  Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.

Authors:  Rong Yan; Kang Li; Da-Wei Yuan; Hao-Nan Wang; Yong Zhang; Cheng-Xue Dang; Kun Zhu
Journal:  Int J Oncol       Date:  2018-10-12       Impact factor: 5.650

9.  miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8.

Authors:  Yao Liu; Bing Zhang; Tiefeng Shi; Huadong Qin
Journal:  Onco Targets Ther       Date:  2017-02-24       Impact factor: 4.147

10.  miR-106b-5p promotes cell proliferation and cell cycle progression by directly targeting CDKN1A in osteosarcoma.

Authors:  Chuan He; Hongwei Chen; Yan Liu; Xiaolin Li; Chaoju Zhang; Qunyan Qin; Qixiong Pang
Journal:  Exp Ther Med       Date:  2020-03-06       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.